Lloyds Banking Group’s Edwards Lifesciences EW Stock Holding History

Lloyds Banking Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-24,336	Closed	-$414K	–	173
2014 Q3	$414K	Buy	24,336 +21,336	+711%	+$337K	0.11%	197
2014 Q2	$42K	Sell	3,000 -118,248	-98%	-$1.6M	0.01%	444
2014 Q1	$1.5M	Sell	121,248 -16,134	-12%	-$186K	0.01%	483
2013 Q4	$1.5M	Buy	137,382 +20,694	+18%	+$233K	0.01%	495
2013 Q3	$1.35M	Sell	116,688 -8,118	-7%	-$95K	0.01%	482
2013 Q2	$1.4M	Buy	+124,806	New	+$1.48M	0.01%	462

Other funds holding EW

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lloyds Banking Group's EW Position: Q4 2014 in Review

Lloyds Banking Group sold out of Edwards Lifesciences (EW) in Q4 2014, closing a stake of 24,336 shares — an estimated $414K sold.

Lloyds Banking Group first reported a position in EW in Q2 2013 and held it in 6 quarters. The position peaked at $1.5M in Q4 2013. 557 funds tracked by Wall St. Rank hold EW as of Q4 2014.

Lloyds Banking Group reported no remaining Edwards Lifesciences position as of Q4 2014 after selling out during the quarter.
Lloyds Banking Group sold 24,336 Edwards Lifesciences shares in Q4 2014, an estimated $414K.
Lloyds Banking Group first reported a position in Edwards Lifesciences in Q2 2013 and held it in 6 quarters.
Lloyds Banking Group's Edwards Lifesciences position peaked at $1.5M in Q4 2013.
557 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2014.

Based on Lloyds Banking Group's 13F filing for Q4 2014, filed 12 Feb 2015.